Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C48H82O18 |
Molecular Weight | 947.1539 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 26 / 26 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]3([H])[C@@]4(C)CC[C@H](O)C(C)(C)[C@]4([H])[C@H](C[C@@]23C)O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@](C)(CCC=C(C)C)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O
InChI
InChIKey=PWAOOJDMFUQOKB-WCZZMFLVSA-N
InChI=1S/C48H82O18/c1-21(2)11-10-14-48(9,66-42-38(60)35(57)32(54)26(19-49)63-42)23-12-16-46(7)30(23)24(51)17-28-45(6)15-13-29(52)44(4,5)40(45)25(18-47(28,46)8)62-43-39(36(58)33(55)27(20-50)64-43)65-41-37(59)34(56)31(53)22(3)61-41/h11,22-43,49-60H,10,12-20H2,1-9H3/t22-,23-,24+,25-,26+,27+,28+,29-,30-,31-,32+,33+,34+,35-,36-,37+,38+,39+,40-,41-,42-,43+,45+,46+,47+,48-/m0/s1
Molecular Formula | C48H82O18 |
Molecular Weight | 947.1539 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 26 / 26 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/21884006 https://www.ncbi.nlm.nih.gov/pubmed/27840193
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/21884006 https://www.ncbi.nlm.nih.gov/pubmed/27840193
Ginsenoside B2 is a constituent of Panax ginseng (ginseng) and Panax japonicum (Japanese ginseng). Ginsenoside B2 belongs to the family of Triterpene Glycosides. Many reports demonstrated that Ginsenoside B2 possesses the multifaceted beneficial pharmacological effects on cardiovascular system. Ginsenoside B2 has negative effect on cardiac contractility and autorhythmicity. It causes alternations in cardiac electrophysiological properties, which may account for its antiarrhythmic effect. In addition, Ginsenoside B2 also exerts antiischemic effect and induces angiogenic regeneration. Ginsenoside B2 is an extract from Panax notoginseng, which is a well-known traditional Chinese medicine that has been used for the treatment of various diseases for years. Ginsenoside B2 has been reported to decrease Aβ in Alzheimer's disease animal models. Ginsenoside B2 is a component of Korean Red Ginseng. The ginsenoside content of the red ginseng is shown as Rg1: 3.3 mg/g, Re (B2): 2.0 mg/g, Rb1: 5.8 mg/g, Rc: 1.7 mg/g, Rb2: 2.3 mg/g, and Rd: 0.4 mg/g, respectively. Korean ginseng (Panax ginseng Meyer, Araliaceae) is traditionally used as an important herbal medicine in Far East Asia. Korean Red Ginseng is possibly effective for:
• Alzheimer's disease. Evidence shows that taking Panax ginseng root daily for 12 weeks can improve mental performance in people with Alzheimer's disease.
• Lung disease called chronic obstructive pulmonary disease (COPD). Taking Panax ginseng by mouth seems to improve lung function and some symptoms of COPD.
• Mental function. Taking Panax ginseng by mouth might improve abstract thinking, mental arithmetic skills, and reaction times in healthy, middle-aged people but not in young adults. Panax ginseng alone does not seem to improve memory. But there is some evidence that a combination of Panax ginseng and ginkgo leaf extract can improve memory in otherwise healthy people between the ages of 38 and 66.
• Erectile dysfunction (ED). Taking Panax ginseng by mouth seems to improve sexual function in men with erectile dysfunction.
• Flu. Taking a specific Panax ginseng by mouth appears to reduce the risk of getting a cold or the flu. But, taking Panax ginseng does not seem to reduce flu symptoms or the length of the illness.
• Multiple sclerosis-related fatigue. Taking Panax ginseng daily for 3 months reduces feelings of tiredness and improves quality of life in females with MS.
• Premature ejaculation. Applying a cream containing Panax ginseng, angelica root, Cistanches deserticola, Zanthoxyl species, torlidis seed, clover flower, asiasari root, cinnamon bark, and toad venom (SS Cream) to the penis one hour before intercourse and washing off immediately before intercourse seems to help prevent premature ejaculation.
• Sexual arousal. Taking powdered Korean red ginseng, a specific form of Panax ginseng, seems to improve sexual arousal and satisfaction in postmenopausal women.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL235 |
|||
Target ID: GO:0034142 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27080948 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02204826
KRG extract contained 1.71mg/g Ginsenoside B2, as well as ginsenoside-Rb1: 4.26mg/g, -Rb2: 1.62mg/g, -Rc: 1.80mg/g, -Rd: 0.29mg/g, -Rf: 0.67mg/g, -Rg1: 2.61mg/g, -Rg2: 0.20mg/g, -Rg3: 0.13mg/g, and other minor ginsenosides. During the study period, three capsules (500 mg/dose) were taken daily for 12 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27073742
Ginsenoside B2 (10 uM) strongly reduced cell loss and degeneration and significantly protected process lengths and numbers of neurites of murine tyrosine hydroxylase (TH+) cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 13:21:16 GMT 2023
by
admin
on
Sat Dec 16 13:21:16 GMT 2023
|
Record UNII |
46F3R0BL3I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C049864
Created by
admin on Sat Dec 16 13:21:16 GMT 2023 , Edited by admin on Sat Dec 16 13:21:16 GMT 2023
|
PRIMARY | |||
|
441921
Created by
admin on Sat Dec 16 13:21:16 GMT 2023 , Edited by admin on Sat Dec 16 13:21:16 GMT 2023
|
PRIMARY | |||
|
52286-59-6
Created by
admin on Sat Dec 16 13:21:16 GMT 2023 , Edited by admin on Sat Dec 16 13:21:16 GMT 2023
|
PRIMARY | |||
|
DTXSID801317298
Created by
admin on Sat Dec 16 13:21:16 GMT 2023 , Edited by admin on Sat Dec 16 13:21:16 GMT 2023
|
PRIMARY | |||
|
308877
Created by
admin on Sat Dec 16 13:21:16 GMT 2023 , Edited by admin on Sat Dec 16 13:21:16 GMT 2023
|
PRIMARY | |||
|
46F3R0BL3I
Created by
admin on Sat Dec 16 13:21:16 GMT 2023 , Edited by admin on Sat Dec 16 13:21:16 GMT 2023
|
PRIMARY | |||
|
77148
Created by
admin on Sat Dec 16 13:21:16 GMT 2023 , Edited by admin on Sat Dec 16 13:21:16 GMT 2023
|
PRIMARY | |||
|
DB14815
Created by
admin on Sat Dec 16 13:21:16 GMT 2023 , Edited by admin on Sat Dec 16 13:21:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|